Smart Tumor Cell‐Derived DNA Nano‐Tree Assembly for On‐Demand Macrophages Reprogramming

Author:

Chen Zhiguo12,Yang Sha1,Zhao Zhuyang1,Feng Liu1,Sheng Jing1,Deng Ruijia1,Wang Binpan1,He Yuan1,Luo Dan3,Chen Ming1,Chen Lei2,Chang Kai1ORCID

Affiliation:

1. Department of Clinical Laboratory Medicine, Southwest Hospital Army Medical University (Third Military Medical University) 30 Gaotanyan, Shapingba District Chongqing 400038 China

2. Department of Gastroenterology, Southwest Hospital Army Medical University (Third Military Medical University) 30 Gaotanyan, Shapingba District Chongqing 400038 China

3. Department of Biological and Environmental Engineering Cornell University Ithaca NY 14853‐5701 USA

Abstract

AbstractWithout coordinated strategies to balance the population and activity of tumor cells and polarized macrophages, antitumor immunotherapy generally offers limited clinical benefits. Inspired by the “eat me” signal, a smart tumor cell‐derived proximity anchored non‐linear hybridization chain reaction (Panel‐HCR) strategy is established for on‐demand regulation of tumor‐associated macrophages (TAMs). The Panel‐HCR is composed of a recognition‐then‐assembly module and a release‐then‐regulation module. Upon recognizing tumor cells, a DNA nano‐tree is assembled on the tumor cell surface and byproduct strands loaded with CpG oligodeoxynucleotides (CpG‐ODNs) are released depending on the tumor cell concentration. The on‐demand release of CpG‐ODNs can achieve efficient regulation of M2 TAMs into the M1 phenotype. Throughout the recognition‐then‐assembly process, tumor cell‐targeted bioimaging is implemented in single cells, fixed tissues, and living mice. Afterward, the on‐demand release of CpG‐ODNs regulate the transformation of M2 TAMs into the M1 phenotype by stimulating toll‐like receptor 9 to activate the NF‐κB pathway and increasing inflammatory cytokines. This release‐then‐regulation process is verified to induce strong antitumor immune responses both in vitro and in vivo. Altogether, this proposed strategy holds tremendous promise for on‐demand antitumor immunotherapy.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing Municipality

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3